Skip to content

A Sweetener Intervention Study Based on Taste Threshold Characteristics in Burning Mouth Syndrome Patients

A Sweetener Intervention Study Based on Taste Threshold Characteristics in Burning Mouth Syndrome Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128683
Enrollment
Unknown
Registered
2026-07-23
Start date
2026-07-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burning Mouth Syndrome

Interventions

BMS group (within-subject pre–post comparison):Localized sweet stimulation with a glucose solution based on the individual sweet taste threshold
Non-BMS group:N/A

Sponsors

Peking University Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: BMS Group: 1. Aged 18 years or older; 2. A diagnosis of burning mouth syndrome (BMS) confirmed by at least two experienced oral medicine specialists, based on the Evidence-Based Clinical Practice Guidelines for Burning Mouth Syndrome and the diagnostic criteria of the International Classification of Orofacial Pain (ICOP). All participants must report a burning sensation or pain involving at least the dorsum of the tongue; 3. No evidence of local or systemic conditions that may cause burning mouth symptoms or affect taste function or saliva-related parameters, as determined by medical-history taking; review of previous medical records, examination results, or health examination reports obtained within the previous year; oral examination; and laboratory test results. Relevant conditions include, but are not limited to, iron, folate, or vitamin B12 deficiency; diabetes mellitus; anemia; malignant tumors; gastroesophageal reflux disease; Helicobacter pylori infection; thyroid dysfunction; and oral candidiasis. Non-BMS Group: 1. Aged 18 years or older; 2. No complaint of orofacial pain or unexplained oral discomfort; 3.No obvious oral mucosal lesions on oral examination.

Exclusion criteria

Exclusion criteria: 1.BMS Group: 1. Participants who have communication difficulties or refuse to participate in clinical follow-up; 2. Participants who smoke; 3. Participants with other oral mucosal diseases; 4. Participants who have received antibiotic therapy, immunosuppressive agents, cytotoxic drugs, or glucocorticoids within the previous 2 months; 5. Participants with apparent local oral factors that may affect taste assessment, salivary testing, or the evaluation of oral pain/discomfort, including: (1) Teeth with conditions or local irritants that may cause mucosal pain, such as pulpitis, apical periodontitis, pericoronitis, cracked teeth, residual roots or crowns, sharp cusps, or periodontal abscesses; (2) Severe dentin hypersensitivity (Schiff Cold Air Sensitivity Scale score >= 2 or pain induced by cold stimulation with a visual analogue scale [VAS] score >= 7), or extensive deep carious lesions with sensitivity to cold, sour, or sweet stimuli that precludes taste-threshold testing; 6. Participants with autoimmune diseases; 7. Female participants who are pregnant or breastfeeding. Non-BMS Group: 1. Participants who have communication difficulties or refuse to participate in clinical follow-up; 2. Participants who smoke; 3. Participants with other oral mucosal diseases; 4. Participants with local or systemic factors that may cause oral discomfort, affect taste function, or influence saliva-related parameters, as identified through medical-history taking; review of previous medical records, previous examination results, or health examination reports obtained within the past year; and oral examination; These factors include, but are not limited to, iron, folate, or vitamin B12 deficiency; diabetes mellitus; anemia; malignant tumors; gastroesophageal reflux disease; Helicobacter pylori infection; thyroid dysfunction; and oral candidiasis; Participants with incomplete previous medical information for whom the above conditions cannot be clearly excluded through history screening will not be enrolled in this study. 5. Participants who have received antibiotic therapy, immunosuppressive agents, cytotoxic drugs, or glucocorticoids within the past 2 months. 6. Participants with obvious local oral factors that may affect taste assessment, salivary testing, or the evaluation of oral pain/discomfort, including: (1) Teeth with conditions or local irritants that may cause mucosal pain, such as pulpitis, apical periodontitis, pericoronitis, cracked teeth, residual roots or crowns, sharp cusps, or periodontal abscesses; (2) Severe dentin hypersensitivity, defined as a Schiff Cold Air Sensitivity Scale score >= 2 or a visual analogue scale (VAS) score >= 7 induced by cold stimulation, or extensive deep carious lesions with sensitivity to cold, sour, or sweet stimuli that precludes threshold testing; 7. Participants with autoimmune diseases; 8. Female participants who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Sweet taste detection threshold;Change in tongue burning pain intensity assessed by the visual analogue scale (VAS);

Secondary

MeasureTime frame
Salivary physicochemical parameters and related components;Occurrence of study-related adverse events;

Countries

China

Contacts

Public ContactZhimin Yan

Peking University Hospital of Stomatology

yzhimin96@163.com+86 10 82195363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026